Loading the section…
The price of Neuropace, Inc. (NPCE) on October 9, 2026 is 12.67 USD, +2.26% on the day. Over 52 weeks the stock traded between 9.22 USD and 19.60 USD; the price now sits 33% of the way up that range. Over the past year the price changed by +13.84%. Market capitalization is 429.63 million USD, rank 45 among 98 stocks of the same industry with a known capitalization.
Closing prices for 9 October 2026
Next earnings report: 3 November 2026 · Earnings calendar
Change over the period shown (line colour): +20.90 %
Neuropace, Inc. trades on Nasdaq under the ticker NPCE. The company belongs to the Health care sector. The trading history on this page starts on 22 April 2021.
Over the past 52 weeks NPCE has traded between 9.22 $ and 19.60 $. As of 9 October 2026 the price stood 33.24 % of the way from the 52-week low to the high.
Over one year NPCE shares rose 13.84 %; over six months they fell 11.15 %. Volatility over 90 days is 48.81 %. Dividends are not included: this is price change only, as of 9 October 2026.
The company reported a loss over the last four quarters, so a price-to-earnings ratio is not calculated. Price to sales is 4.3, above the sector median of 4.0. Price to book is 29.7, above the sector median of 2.5. Calculated from reports for the period ending 31 March 2026.
| Date | Open | High | Low | Close | Volume, shares |
|---|---|---|---|---|---|
| 9 October 2026 | 12.39 | 12.70 | 12.38 | 12.67 | 72,500 |
| 8 October 2026 | 12.66 | 12.66 | 12.28 | 12.39 | 142,600 |
| 7 October 2026 | 12.58 | 13.06 | 12.51 | 12.76 | 127,200 |
| 6 October 2026 | 13.38 | 13.38 |
The series is stated in the current share scale after splits; dividends are not included in the price
Based on the last 12 months of reports, through 31 March 2026
The sector median covers every company in the sector on the US market, loss-making ones included.
No news about this security in English yet.
Address:455 N. BERNARDO AVENUE, MOUNTAIN VIEW, CA, 94043, US
Neuropace, Inc. reported revenue of 100M $ and a net loss of 22M $ over the last four quarters. Net margin is −21.67 %. Revenue changed by +18.06 % year over year. Earnings per share are −0.65 $. Market capitalisation is 430M $.
NPCE has a return on equity of −149.20 %, below the sector median of −41.68 %. Return on assets is −21.81 %, above the sector median of −32.11 %. Operating margin is −16.84 %, above the sector median of −26.84 %.
| 328M |
| DXCMDexCom, Inc. | 84.11 | −0.36 % | 324M |
| MDLNMedline Inc. | 36.26 | +1.45 % | 297M |
| RMDResMed Inc. | 230.05 | +1.46 % | 271M |
| PODDInsulet Corporation | 135.28 | +0.60 % | 244M |
| 12.66 |
| 12.67 |
| 83,000 |
| 5 October 2026 | 12.64 | 13.26 | 12.50 | 13.22 | 149,400 |
| 2 October 2026 | 13.34 | 13.34 | 12.68 | 12.70 | 120,400 |
| 1 October 2026 | 13.81 | 13.81 | 13.05 | 13.15 | 197,400 |
| 30 September 2026 | 14.02 | 14.06 | 13.73 | 13.76 | 120,900 |
| 29 September 2026 | 14.14 | 14.45 | 13.77 | 13.94 | 100,600 |
| 28 September 2026 | 14.01 | 14.18 | 13.75 | 14.15 | 134,300 |
| 25 September 2026 | 13.95 | 14.18 | 13.75 | 14.06 | 231,400 |
| 24 September 2026 | 14.21 | 14.21 | 13.59 | 13.97 | 186,000 |
| 23 September 2026 | 14.71 | 14.87 | 14.17 | 14.21 | 166,400 |
| 22 September 2026 | 14.75 | 14.94 | 14.54 | 14.71 | 160,200 |
| 21 September 2026 | 14.36 | 14.66 | 14.12 | 14.54 | 71,700 |
| 18 September 2026 | 14.17 | 14.56 | 14.05 | 14.28 | 235,500 |
| 17 September 2026 | 14.34 | 14.34 | 13.97 | 14.15 | 107,800 |
| 16 September 2026 | 14.28 | 14.57 | 14.04 | 14.10 | 116,100 |
| 15 September 2026 | 14.48 | 14.49 | 14.05 | 14.25 | 96,800 |
| 14 September 2026 | 14.01 | 14.66 | 13.95 | 14.59 | 125,900 |